Leading Market and Competitive Intelligence Company within Lifesciences and Healthcare Segment in India
wtadmin July 28, 2021 0 Comments

Lorem ipsum dolor sit amet consectet adipisie cing elit sed eiusmod tempor incididunt on labore et dolore.  Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo. Bccaecat cupidatat non proident,

wtadmin July 28, 2021 0 Comments

Lorem ipsum dolor sit amet consectet adipisie cing elit sed eiusmod tempor incididunt on labore et dolore.  Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo. Bccaecat cupidatat non proident,

wtadmin July 28, 2021 0 Comments

Lorem ipsum dolor sit amet consectet adipisie cing elit sed eiusmod tempor incididunt on labore et dolore.  Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo. Bccaecat cupidatat non proident,

wtadmin July 28, 2021 0 Comments

Lorem ipsum dolor sit amet consectet adipisie cing elit sed eiusmod tempor incididunt on labore et dolore.  Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo. Bccaecat cupidatat non proident,

wtadmin July 28, 2021 0 Comments

Lorem ipsum dolor sit amet consectet adipisie cing elit sed eiusmod tempor incididunt on labore et dolore.  Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo. Bccaecat cupidatat non proident,

wtadmin July 28, 2021 0 Comments

Lorem ipsum dolor sit amet consectet adipisie cing elit sed eiusmod tempor incididunt on labore et dolore.  Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo. Bccaecat cupidatat non proident,

wtadmin July 28, 2021 0 Comments

Lorem ipsum dolor sit amet consectet adipisie cing elit sed eiusmod tempor incididunt on labore et dolore.  Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo. Bccaecat cupidatat non proident,

wtadmin July 28, 2021 0 Comments

BDR Pharmaceutical launched BDPARIB (RUCAPARIB) to treat advanced ovarian and prostate cancers today. BDPARIB is the first affordable generic in the India available in the form of a tablet, with the cost of therapy less expensive than

wtadmin July 28, 2021 0 Comments

Drug major on Thursday said it has received payment of USD 50 million (around Rs 363.5 crore) from Germany-based Boehringer Ingelheim for achievement of key milestones by its novel cancer drug, a potential target therapy for patients

wtadmin July 28, 2021 0 Comments

Novartis announced robust data from the primary analysis of the pivotal phase II ELARA trial of Kymriah (tisagenlecleucel) in patients with relapsed or refractory (r/r) follicular lymphoma (FL). Data will be presented as an oral presentation during